For users applies:
Legally, people in need of care are entitled to a supplementary benefit from a DiPA if necessary in the individual case. The decision on the entitlement to reimbursement lies with the long-term care insurance fund. A price cap of up to 50 euros per month can be claimed for reimbursement. If the DiPA is more expensive, users have to pay the additional costs themselves.
For manufacturers applies:
Inclusion in the DiPA directory is not yet possible, as the Federal Institute for Drugs and Medical Devices (german: BfArM) has yet to create the basis. However, it is certain that a complete, digital application for inclusion in the list must be submitted to the BfArM. Within three months, the institute will decide whether to approve or reject the application.
It is also worth knowing that the remuneration amount as well as the technical and contractual framework conditions of the DiPA must be negotiated with the german Spitzenverband Bund der Pflegekassen within three months after inclusion in the directory.
The legal text § 78a SGB XI compactly summarises the applicable regulatory requirements.
Requirements must be met in terms of:
Quality features are also
According to the BfArM, DiGA assist in diagnosing, monitoring, treating or alleviating diseases, injuries or disabilities. Compensation for injuries or disabilities can also be made possible.
DiPA, on the other hand, are aimed specifically at people in need of care as well as their caregivers (relatives as well as care services). In addition to the target group of the applications, however, there are other significant differences – an overview:
BAYOOMED @DMEA 2022 
